Literature DB >> 17129212

Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging.

Bethany M Tesar1, Wendy E Walker, Julia Unternaehrer, Nikhil S Joshi, Anmol Chandele, Laura Haynes, Susan Kaech, Daniel R Goldstein.   

Abstract

The immune response is the result of the interplay between innate and adaptive immunity, yet the impact of aging on this interaction is unclear. Addressing this fundamental question will be critical for the development of effective vaccines for the rapidly rising older subpopulation that manifests increased prevalence of malignancies and infections. Therefore, we undertook the current study to investigate whether aging impairs toll-like receptor (TLR) function in myeloid dendritic cells and whether this leads to reduced T-cell priming. Our results demonstrate that innate TLR immune priming function of myeloid bone marrow derived and splenic dendritic cells (DC) is preserved with aging using both allogeneic and infectious murine experimental systems. In contrast, aging impairs in vitro and in vivo intrinsic T-cell function. Therefore, our results demonstrate that myeloid DCs manifest preserved TLR-mediated immune responses with aging. However, aging critically impairs intrinsic adaptive T-cell function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17129212     DOI: 10.1111/j.1474-9726.2006.00245.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  46 in total

1.  GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.

Authors:  Hayedeh Behzad; Anke L W Huckriede; Laura Haynes; Beth Gentleman; Krysta Coyle; Jan C Wilschut; Tobias R Kollmann; Steven G Reed; Janet E McElhaney
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

Review 3.  Impact of aging on dendritic cell functions in humans.

Authors:  Anshu Agrawal; Sudhir Gupta
Journal:  Ageing Res Rev       Date:  2010-07-07       Impact factor: 10.895

4.  Enhancement of virus-specific expansion of transgenic CD8 T cells in aged mice by dendritic cells.

Authors:  Jiu Jiang; Erin Fisher; Andrew J Bennett; Donna M Murasko
Journal:  Mech Ageing Dev       Date:  2010-08-20       Impact factor: 5.432

Review 5.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

Review 6.  Biology of dendritic cells in aging.

Authors:  Anshu Agrawal; Sudhanshu Agrawal; Jia Tay; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

Review 7.  Potential role of statins in the treatment of heart failure.

Authors:  Stuart D Katz
Journal:  Curr Atheroscler Rep       Date:  2008-08       Impact factor: 5.113

Review 8.  Impact of aging on antigen presentation cell function of dendritic cells.

Authors:  Christine Wong; Daniel R Goldstein
Journal:  Curr Opin Immunol       Date:  2013-06-24       Impact factor: 7.486

9.  Proton irradiation augments the suppression of tumor progression observed with advanced age.

Authors:  Afshin Beheshti; Michael Peluso; Clare Lamont; Philip Hahnfeldt; Lynn Hlatky
Journal:  Radiat Res       Date:  2014-02-25       Impact factor: 2.841

10.  Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation.

Authors:  Heather W Stout-Delgado; Xin Yang; Wendy E Walker; Bethany M Tesar; Daniel R Goldstein
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.